华润三九营收利润双双两位数增长!收购天士力有望提升盈利能力

新民周刊2025-03-13

这也将使天士力成为昆药集团之后又一家被华润三九并表的医药上市企业。从财务视角看,天士力2024年的整体毛利率为67.14%,明显高于华润三九的51.86%,如果管理协同得当,理论上将会进一步提升华润三九的盈利能力。3月12日,华润三九医药股份有限公司(000999.SZ,以下简称:华润三九)同时披露年报等多份重磅报告,全面呈现其2024年的发展图景。在中药行业政策调整、市场竞争加剧的背景下,这家...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment